Literature DB >> 18081476

Multisession CyberKnife radiosurgery for optic nerve sheath meningiomas.

Pantaleo Romanelli1, Berndt Wowra, Alexander Muacevic.   

Abstract

Optic nerve sheath meningiomas (ONSMs) are benign lesions originating from the dural sheath of the optic nerve. Progressive growth can lead to gradual loss of vision and exophthalmos. Loss of vision following microsurgical resection is not uncommon, and although stereotactic fractionated radiotherapy can be a safe alternative to control tumor growth and preserve vision, it may also lead to complications. Frame-based stereotactic radiosurgery has only been rarely used because single-fraction high-dose treatments of intrinsic optic nerve lesions may induce unacceptably high toxicity. New frameless radiosurgery devices such as the robotic CyberKnife, an image-guided radiosurgery system, can provide the extremely tight conformality and submillimetric accuracy of frame-based systems combined with the possibility of delivering radiation in several sessions. In the present report the authors review the clinical presentation and management of ONSMs and describe their preliminary experience using multisession radiosurgery to treat these lesions.

Entities:  

Mesh:

Year:  2007        PMID: 18081476     DOI: 10.3171/FOC-07/12/E11

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  9 in total

1.  Hypofractionated stereotactic radiosurgery for large-sized skull base meningiomas.

Authors:  Hyuk-Jin Oh; Young Hyun Cho; Jeong Hoon Kim; Chang Jin Kim; Do Hoon Kwon; Doheui Lee; KyoungJun Yoon
Journal:  J Neurooncol       Date:  2020-07-01       Impact factor: 4.130

2.  Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery.

Authors:  Putipun Puataweepong; Mantana Dhanachai; Ake Hansasuta; Somjai Dangprasert; Chomporn Sitathanee; Rawee Ruangkanchanasetr; Pornpan Yongvithisatid
Journal:  J Neurooncol       Date:  2018-05-30       Impact factor: 4.130

3.  [Chronic uveitis with secondary glaucoma?].

Authors:  I Huebert; A Muacevic; A Kampik; K H Eibl-Lindner
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

4.  Primary and Secondary Optic Nerve Sheath Meningioma.

Authors:  Elena Solli; Roger E Turbin
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

5.  Prolonged vision return after radiosurgery for an optic nerve-sheath meningioma.

Authors:  Ali Kooshkabadi; Ismayilov Elchin; Hideyuki Kano; L Dade Lunsford
Journal:  J Radiosurg SBRT       Date:  2012

6.  Effectiveness and Safety of Robotic Radiosurgery for Optic Nerve Sheath Meningiomas: A Single Institution Series.

Authors:  Carolin Senger; Anne Kluge; Melina Kord; Zoe Zimmermann; Alfredo Conti; Markus Kufeld; Anita Kreimeier; Franziska Loebel; Carmen Stromberger; Volker Budach; Peter Vajkoczy; Gueliz Acker
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

7.  CyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerations.

Authors:  Alfredo Conti; Antonio Pontoriero; Federica Midili; Giuseppe Iatì; Carmelo Siragusa; Chiara Tomasello; Domenico La Torre; Salvatore M Cardali; Stefano Pergolizzi; Costantino De Renzis
Journal:  Springerplus       Date:  2015-01-30

Review 8.  Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy.

Authors:  Jimm Grimm; Tamara LaCouture; Raymond Croce; Inhwan Yeo; Yunping Zhu; Jinyu Xue
Journal:  J Appl Clin Med Phys       Date:  2011-02-08       Impact factor: 2.243

9.  Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis.

Authors:  Conti Alfredo; Senger Carolin; Acker Güliz; Kluge Anne; Pontoriero Antonio; Cacciola Alberto; Pergolizzi Stefano; Germanò Antonino; Badakhshi Harun; Kufeld Markus; Meinert Franziska; Nguyen Phuong; Loebel Franziska; Vajkoczy Peter; Budach Volker; Kaul David
Journal:  Radiat Oncol       Date:  2019-11-12       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.